Institutional Ownership Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN). We have compiled data on the 628 institutions that hold shares in the stock, with a total of 183 Million shares, which have been reported (via 13F filing form) to have a value of $13 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
460,000
shares
|
$32.8 Million
0.13% of portfolio
|
Q4 2024
Added 4.26%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
453,936
shares
|
$32.4 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Camber Capital Management LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
450,000
shares
|
$32.1 Million
0.68% of portfolio
|
Q4 2024
New holding
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
449,761
shares
|
$32.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 7.34%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
435,871
shares
|
$31.1 Million
0.05% of portfolio
|
Q4 2024
Added 4.06%
|
|
|
Swedbank Ab
Stockholm, V7 |
Jan 23, 2025 Q4 2024 |
432,122
shares
|
$30.8 Million
0.04% of portfolio
|
Q4 2024
New holding
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Feb 12, 2025 Q4 2024 |
419,212
shares
|
$29.9 Million
6.77% of portfolio
|
Q3 2024
Added 80.85%
|
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Feb 12, 2025 Q4 2024 |
412,299
shares
|
$29.4 Million
0.08% of portfolio
|
Q4 2024
Reduced 15.1%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
408,156
shares
|
$29.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 36.49%
|
|
|
Amundi
Paris, I0 |
Feb 07, 2025 Q4 2024 |
399,238
shares
|
$28.5 Million
0.01% of portfolio
|
Q4 2024
Added 28.38%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
387,613
shares
|
$27.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 67.82%
|
|
|
Clearline Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
377,482
shares
|
$26.9 Million
3.61% of portfolio
|
Q4 2024
Added 18.05%
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
367,765
shares
|
$26.2 Million
35.97% of portfolio
|
Q4 2022
Reduced 51.55%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Feb 10, 2025 Q4 2024 |
356,496
shares
|
$25.4 Million
0.12% of portfolio
|
Q4 2024
Added 206.64%
|
|
|
Motley Fool Wealth Management, LLC
Alexandria, VA |
Feb 11, 2025 Q4 2024 |
347,728
shares
|
$24.8 Million
1.27% of portfolio
|
Q4 2024
Reduced 18.1%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
337,103
shares
|
$24 Million
0.03% of portfolio
|
Q4 2024
Reduced 62.98%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
329,021
shares
|
$23.5 Million
0.43% of portfolio
|
Q4 2024
Reduced 0.59%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
328,866
shares
|
$23.5 Million
0.01% of portfolio
|
Q4 2024
Added 14.35%
|
|
|
C World Wide Group Holding A
|
Feb 04, 2025 Q4 2024 |
303,851
shares
|
$21.7 Million
0.24% of portfolio
|
Q4 2023
Added 19.7%
|
|
|
Rockefeller Capital Management L.P.
New York, NY |
Feb 13, 2025 Q4 2024 |
302,500
shares
|
$21.6 Million
0.06% of portfolio
|
Q4 2024
Added 13.45%
|
|
|
Ray Dalio
Bridgewater Associates, LP | Westport, Ct
|
Feb 13, 2025 Q4 2024 |
302,480
shares
|
$21.6 Million
0.09% of portfolio
|
Q4 2024
Added 112.54%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
286,650
shares
|
$20.4 Million
0.02% of portfolio
|
Q1 2024
Reduced 8.12%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
284,700
shares
|
$20.3 Million
0.02% of portfolio
|
Q4 2024
Reduced 69.04%
|
|
|
Deka Bank Deutsche Girozentrale
|
Jan 29, 2025 Q4 2024 |
280,330
shares
|
$20 Million
0.03% of portfolio
|
Q3 2024
Reduced 0.27%
|
|
|
Worldquant Millennium Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
278,118
shares
|
$19.8 Million
0.12% of portfolio
|
Q4 2024
Added 337.49%
|